Brook Byers has been a venture capital investor since 1972. He has been closely involved with founders to help build more than 60 new technology-based companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led Kleiner Perkins to become a premier venture capital firm in the life sciences, healthcare and biotechnology sectors.

Brook was the founding president and then chairman of four biotechnology companies that were incubated in Kleiner Perkins’ offices and went on to become public companies with an aggregate market value of more than US$8 billion. He currently serves on the board of directors of Arsenal Bio, Octave Bio, Newsela and Verana Health. Brook serves on the board of the Stanford Center for BioDesign and is a Lifetime Board Member of the University of California San Francisco Medical Center. He served on the Board of Trustees of Stanford University, the Asian Art Museum in San Francisco and the Georgia Tech Advisory Board. He was also a founder of TechNet.

Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University. He received an Honorary PhD from Georgia Tech.